Metered-dose inhalers I: Drug content and particle size distribution of beclomethasone dipropionate

Journal of Pharmaceutical and Biomedical Analysis

Volumn 14, Issue 7, 1996, Pages 793-800

  LeBelle, Michael ^a   Pike, Richard K ^a,c   Graham, Susan J ^a   Ormsby, Eric D ^b   Bogard, Heather A ^a  

^a Bureau of Drug Research   (Canada)

^b HEALTH CANADA   (Canada)

^c Geripharm Inc   (Canada)

Author keywords

Anderson cascade impactor; Beclomethasone dipropionate; Content uniformity; Metered dose inhalers; Particle size distribution

Indexed keywords

BECLOMETASONE DIPROPIONATE;

AEROSOL; AIRFLOW; ARTICLE; BIOEQUIVALENCE; DRUG DELIVERY SYSTEM; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; PARTICLE SIZE; PHYSICAL CHEMISTRY; PRIORITY JOURNAL;

EID: 0029901372     PISSN: 07317085     EISSN: None     Source Type: Journal    
DOI: 10.1016/0731-7085(96)01730-X     Document Type: Article

References (19)

1. S.J. Graham, E.D. Ormsby and E.G. Levering, Pharm. Forum, 18 (1992) 4400-4403.
2. T.D. Cyr, S.J. Graham, K.-Y.R. Li and E.G. Lovering, Pharm. Res., 8 (1991) 658-660.
3. R.M. Duhaime, S.J. Graham, R.C. Lawrence, E.D. Ormsby and E.G. Lovering, Pharm. Forum, 20 (1994) 6944-6947.
4. E.F. Fiese, W.G. Gorman, D. Dolinsky, R.J. Harwood, W.A. Hunke, N.C. Miller, H. Mintzer and N.J. Harper, J. Pharm. Sci., 77 (1988) 90-93.
5. Members of the USP Advisory Panel on Aersols (E.L. Kelly. Chairman), Pharm. Forum. 20 (1994) 7878-7884.
6. The United States Pharmacopoeia, 〈601〉 Aerosols, The United States Pharmacopoeia Convention Inc., Rockville, MD, 1995, pp. 1760-1767.
7. Recommendations of the USP Advisory Panel on Aerosols on the USP General Chapters on Aerosols 〈601〉 and Uniformity of Dosage Units 〈905〉 (P. Byron, Chairman), Pharm. Forum, 20 (1994) 7477-7503.
8. European Pharmacopoeia Commission Group of Experts No. 12, Pharmeuropa, 5 (1993) 315-328.
9. S.J. Graham, R.C. Lawrence, E.D. Ormsby and R.K. Pike, Pharm. Res., 12 (1995) 1380-1384.
10. Physician's Desk Reference, Beclovent Monograph, Medical Economics Data Production Company, Montvale, NJ 1994, pp. 474-475.
11. S.P. Newman and C.J. Kenyon, Pharm. J., 253 (1994) 42.
12. M. Mulholland and D. Rudd, Anal. Proc., 22 (1985) 140-141.
13. R. Sane, V. Bhate, V. Nayak, R. Tendolkar and D. Gangal, Indian Drugs, 28 (1990) 90-93.
14. SAS/STAT™ User's Guide, Release 6.03 Edition, SAS Institute Inc., Cary, NC, 1988.
15. The United States Pharmacopoeia, 〈905〉 Uniformity of Dosage Units, The United States Pharmacopoeia Convention Inc., Rockville, MD, 1995, pp. 1838-1839.
16. I. Gonda, Int. J. Pharmaceutics, 27 (1985) 99-116.
17. H.-K. Kim and I. Gonda, Int. J. Pharmaceutics, 41 (1988) 147-157.
18. J. Webb, DIA Workshop: MDIs in the New Millennium, Toronto, Canada, 18-19 October, 1993.
19. J. Webb, 2nd Int. Conf. on Pharmaceutical Aerosols, Basle, Switzerland, 1-3 June, 1994.